Horn, DO, MPH, DABOM, MFOMA, medical director at the University of Texas Center for Obesity Medicine and Metabolic Performance and clinical assistant professor in the department of surgery at University of Texas McGovern Medical School in Houston, said the weight loss observed in ATTAIN-2 was lower than what was observed in ATTAIN-1, but added that adults with type 2 diabetes usually lose less weight with obesity pharmacotherapy than the nondiabetes population
In one study, the average semaglutide patient lost over 10% of their body weight (e.g
Second, the behavioral infrastructure: has the patient established exercise habits, dietary patterns, and sleep hygiene that can partially buffer against regain
However, standard capsules can sometimes cause mild bloating or gas, which might feel uncomfortable for those with sensitive stomachs
L.ChiangS.KalinowskiD
Delivers triple-layer brightening with Vita Complex for enhanced skin clarity and a luminous glow